Integration of a podcast curriculum (PC) to improve hematology oncology fellow (HOF) knowledge: A multi-center cluster randomized control trial.
Abstract
9001 Background: Medical podcasts are widely used as learning resources, yet their integration into fellowship curricula remains unstudied. We present the final analysis of a multicenter cluster randomized trial comparing a supplemental PC with the standard curriculum (SC) to SC alone for HOFs. Methods: Twenty-seven U.S. HOF programs were randomized to receive a novel PC with SC (podcast arm) or SC alone (control arm). The PC arm accessed a website with links to podcast episodes (PEs) and show notes covering breast cancer (BC), myeloma (MM), bleeding disorders (BD), and heparin induced thrombocytopenia (HIT). PEs were developed by The Fellow on Call and Two Onc Docs podcasts. Show notes were developed by The Fellow on Call . Pre- and post-intervention qualitative surveys (QS) and knowledge assessments (KA) were administered via REDCap. HOFs rated their comfort managing topics using a 7-point Likert scale. The KA was a 16-question multiple-choice test. ANCOVA analysis was used to compared post-intervention results. This study was powered for dual primary endpoints of mean QS improvement by 0.5 and KA improvement by 10% as previously published. Results: Pre-intervention QS and KA were completed by 220 (52%) and 187 (45%) HOFs, respectively. Post-intervention, 53/107 (49%) HOFs in the podcast arm and 46/113 (40%) in the control arm completed assessments. PGY distribution was similar between podcast and control arms: PGY 4 25% and 37%, PGY 5 32% and 30%, and PGY 6+ 43% and 33% (p=0.38). At baseline, 37 (69%) podcast-arm and 24 (52%) control-arm HOFs listened to medical podcasts. Detailed didactic characteristics for each institution and HOF learning preferences were previously presented. Baseline mean comfort levels (±SD) were comparable in podcast vs. control: BC (4.4±1.5 vs. 4.5±1.4), MM (4.5±1.2 vs. 4.4±1.4), BD (3.9±1.2 vs. 3.7±1.2), and HIT (5.5±1 vs. 5.5±1). Post-intervention paired mean comfort level difference (±SD) significantly improved in the podcast vs. control across topics (p<0.01): BC (1.4±0.4 vs. 0.9±0.2), MM (1.5±0.4 vs. 0.9±0.3), BD (1.6±0.3 vs. 1±0.2), and HIT (1.2±0.6 vs. 0.8±0.4). Composite mean KA improved from 39.7%±18.9 to 62%±19.2 in the podcast arm vs. 43.5%±19.2 to 50.3%±19.8 in the control arm. The podcast arm had significantly greater improvement with an adjusted mean difference of 15.5% (p<0.01). In the podcast arm, 44 (83%) utilized >50% of show notes and found them helpful, and 47 (89%) planned to continue using these podcasts. Results were not impacted after adjusting for baseline podcast use. Conclusions: To our knowledge, this is the largest cluster randomized trial of a pragmatic educational intervention in graduate medical education. The study met its dual primary endpoints, demonstrating that the podcasts significantly improved fellow comfort and knowledge in representative topics. Despite limitations of dropout and respondent bias, findings support integrating these podcasts as a recommended resource in hematology oncology education.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (20)
Vivek Patel
Karine Tawagi
2University of Illinois Chicago, Chicago, United States
Samantha Ann Armstrong
Indiana University School of Medicine, Indianapolis, IN
Daniel Hausrath
2Vanderbilt University Medical Center, Nashville, United States
Inas Abuali
Mass General Brigham Cancer Institute, Boston, MA
Sean Maximillian Taasan
UT Southwestern Medical Center, Dallas, TX
Ankoor Biswas
Aurora Cancer Care, Aurora Health Care, Milwaukee, WI
Jonathan L. Berry
Beth Israel Deaconess Medical Center, Boston, MA
Srijan Valasapalli
4East Carolina State University, Hematology Oncology, Greenville, United States
Kyle Kidwell
University of Alabama at Birmingham, Birmingham, AL
Agrima Mian
1Cleveland Clinic Foundation, Department of Hematology and Medical Oncology, Cleveland, United States
Shivang Danak
Chesapeake Oncology Hematology Associates, Annapolis, MD
Moriah Forster
Vanderbilt University Medical Center, Nashville, TN
Jessica M. Stempel
Division of Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR
Pranali Santhoshini Pachika
Charleston Regional Medical Center, Charleston, WV
Maya Abdallah
2Boston Medical Center, Boston, United States
Sheila DeYoung
Cooper University Hospital, Camden, NJ
Lauren Mendelson
University of Cincinnati, Cincinnati, OH
Megan Elizabeth Melody
Northwestern University Feinberg School of Medicine, Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
Ronak Mistry
2University of Pennsylvania Perelman School of Medicine, Division of Hematology/Oncology, Philadelphia, United States